RAMM Pharma Corp. (CSE:RAMM)
Canada · Delayed Price · Currency is CAD 0.0150
0.00 (0.00%)
May 21, 2026, 9:18 AM EST
RAMM Pharma Company Description
RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations, pharmaceuticals, cosmetics, nutraceutical products, and resale of medical supplies products in Canada and internationally.
It offers Epifractán, a cannabinoid pharmaceutical drug; XALEX 10, a prescription pharmaceutical formulation for the treatment of refractory epilepsy; and NettaLife, a cannabis-based product for pets.
The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019.
RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada.
RAMM Pharma Corp.
| Country | Canada |
| Founded | 1987 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Jackie Burnett |
Contact Details
Address: 200, 82 Richmond St. East Toronto, ON ON Canada | |
| Phone | 416-848-7744 |
Stock Details
| Ticker Symbol | RAMM |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | November - October |
| Reporting Currency | CAD |
| ISIN Number | CA75150G1046 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jackie Peter Burnett | President, Chief Executive Officer and Chairman |
| Jose Roldan | Interim Chief Financial Officer and Corporate Secretary |